These innovative medications , including Rybelsus, belong to a category of drugs called GLP-1 receptor agonists . Initially developed for controlling high blood sugar, they operate by assisting the organism to secrete adequate insulin production and reducing increased glucose levels. Additionally , their capacity to encourage weight management has